Design and evaluation of Poly(δ-decalactone) based nanoemulsions for mitigating Lumiracoxib-associated hepatotoxicity. (PubMed, Int J Pharm) - Sep 29, 2026 - "Evaluation in an in vivo arthritic model further demonstrated NEs capability in reducing LXB-induced hepatic toxicity with improved anti-inflammatory activity. These findings suggest that PDL NEs may offer a promising strategy for improving the biopharmaceutical performance and safety profile of LXB."
Journal • Immunology • Liver Cancer • Oncology • Osteoarthritis • Pain • Rheumatoid Arthritis • Rheumatology • Solid Tumor
|
|
Alexandra Stubelius; Carl-Eric Wilen; Honey Modi; Jessica M Rosenholm; Kuldeep K Bansal; Leila D Rostami; Loise Råberg; Rohit Goyal; Vishal Kumar
|